tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Syngene Schedules Investor Meeting with Goldman Sachs

Story Highlights
Syngene Schedules Investor Meeting with Goldman Sachs

TipRanks Black Friday Sale

Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an update.

Syngene International Ltd. has announced a scheduled meeting with Goldman Sachs on November 28, 2025, in Mumbai. This meeting is part of their ongoing engagement with analysts and institutional investors, and the company has assured that no unpublished price-sensitive information will be disclosed during the meeting.

More about Syngene International Ltd.

Syngene International Ltd. operates in the biotechnology industry, providing integrated research, development, and manufacturing services across various sectors, including pharmaceuticals, biotechnology, and agrochemicals. The company is based in Bengaluru, India, and focuses on delivering customized solutions to its global clientele.

Average Trading Volume: 64,839

Technical Sentiment Signal: Sell

Current Market Cap: 253.7B INR

For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1